BlackRock Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $4.69M | Buy |
250,181
+43,398
| +21% | +$814K | ﹤0.01% | 1117 |
|
2016
Q3 | $3.41M | Buy |
206,783
+194,401
| +1,570% | +$3.21M | ﹤0.01% | 1216 |
|
2016
Q2 | $166K | Buy |
12,382
+374
| +3% | +$5.01K | ﹤0.01% | 2658 |
|
2016
Q1 | $184K | Buy |
12,008
+958
| +9% | +$14.7K | ﹤0.01% | 2555 |
|
2015
Q4 | $219K | Sell |
11,050
-4,954
| -31% | -$98.2K | ﹤0.01% | 2486 |
|
2015
Q3 | $279K | Sell |
16,004
-457
| -3% | -$7.97K | ﹤0.01% | 2503 |
|
2015
Q2 | $333K | Buy |
16,461
+1,128
| +7% | +$22.8K | ﹤0.01% | 2435 |
|
2015
Q1 | $270K | Buy |
15,333
+2,200
| +17% | +$38.7K | ﹤0.01% | 2477 |
|
2014
Q4 | $214K | Sell |
13,133
-624
| -5% | -$10.2K | ﹤0.01% | 2558 |
|
2014
Q3 | $304K | Sell |
13,757
-325
| -2% | -$7.18K | ﹤0.01% | 2311 |
|
2014
Q2 | $283K | Sell |
14,082
-2,271
| -14% | -$45.6K | ﹤0.01% | 2387 |
|
2014
Q1 | $304K | Buy |
16,353
+1,257
| +8% | +$23.4K | ﹤0.01% | 2369 |
|
2013
Q4 | $152K | Buy |
15,096
+218
| +1% | +$2.2K | ﹤0.01% | 2809 |
|
2013
Q3 | $192K | Sell |
14,878
-131,968
| -90% | -$1.7M | ﹤0.01% | 2563 |
|
2013
Q2 | $1.74M | Buy |
+146,846
| New | +$1.74M | ﹤0.01% | 1156 |
|